What are weight loss injections and what’s the controversy?
With new research emerging, more questions have been raised about weight-loss injections, how they work, and the risks involved. Here are some of your questions answered. What are weight loss injections? Championed by some celebrities, including Elon Musk, weight loss injections were originally created to treat people with type 2 diabetes and other weight-related health issues. They are a type of prescription-based medical treatment that interferes with your metabolism, regulates your appetite and as a result encourages weight loss. The drugs belong to a class of medications known as glucagon-like peptide-1 receptor agonists, or GLP-1 RAs, which mimic the GLP-1 hormone, released in the gut after eating some food. The only FDA-approved stomach injections to help with weight management are semaglutide — sold under the brand names Ozempic, Wegovy and Rybelsus — and liraglutide — sold under Saxenda. But others are in development. Helen Knight, programme director of the Centre for Health Technology Evaluation at the National Institute for Health and Care Excellence (Nice) said: “We know that management of overweight and obesity is one of the biggest challenges our health service is facing with nearly two-thirds of adults either overweight or obese. It is a lifelong condition that needs medical intervention, has psychological and physical effects, and can affect the quality of life. “But in recent years Nice has been able to recommend a new line of pharmaceutical treatments which have shown that those people using them, alongside changes to their diet and exercise, have been able to reduce their weight.” How do they work? According to Nice’s independent appraisal committee, drugs like semaglutide should only be prescribed to patients as an alternative for weight management — alongside a reduced-calorie diet and increased physical activity in adults. They should also have a BMI of at least 35.0 kg/m2 (this is medically classified as obese), and especially, to people with a BMI of 30.0 kg/m2 to 34.9 kg/m2, have non-diabetic hyperglycaemia (blood sugar that is above normal but below those needed to diagnose diabetes) or are at high risk of other weight-related conditions such as strokes and heart attacks, due to other factors such as high blood pressure and high cholesterol. Using semaglutide as an example, a typical dose for weight loss is 2.4 milligrams, administered weekly as under-the-skin self-injections. How are they going to be rolled out? Nice formally recommended liraglutide, orlistat and semaglutide as medicines suitable to use for weight loss earlier this year. And with such drugs also available through online pharmacies by private prescription, a growing number of people have tried the jabs. If they are prescribed alongside a reduced-calorie diet, increased physical activity, and behavioural support, after a year, people taking them can lose up to 15% of their body weight, with results visible within the first month, according to the Nice clinical trials. Some weight loss injections are available on the NHS, but they are only prescribed under certain circumstances. Following an announcement of a £40 million two-year pilot on June 7, the government have said more people living with obesity will have access to the newest and most effective obesity drugs to help cut NHS waiting lists. What are the possible side effects? Europe’s drug regulator The European Medicines Agency (EMA) is investigating whether patients using some weight loss and obesity jabs are at risk of suicidal thoughts and thoughts of self-harm, which highlights some of the controversy surrounding the phenomenon. The EMA safety committee said it is looking at cases among people who use a semaglutide or liraglutide-containing medicine for weight loss – where “signals” were raised by the Icelandic Medicines Agency. “A signal is information on a new or known adverse event that is potentially caused by a medicine and that warrants further investigation,” the EMA said. “The case reports included two cases of suicidal thoughts, one following the use of Saxenda and one after Ozempic. One additional case reported thoughts of self-injury with Saxenda. “The semaglutide-containing medicine Wegovy and the liraglutide-containing medicine Saxenda are authorised for weight loss, together with diet and physical activity. “Suicidal behaviour is not currently listed as a side-effect in the EU product information of these medicines.” If you have a history of medullary thyroid cancer, gallbladder disease, or even pancreatitis, you should avoid taking weight loss injections like semaglutide. People who do take the prescription drug for weight loss sometimes experience dizziness, fatigue, and gastrointestinal issues — the most common side effects among patients — such as diarrhoea, constipation and gassiness. They are also at risk of getting headaches and stomach conditions including vomiting, bloating and nausea. Read More Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live Journalist and author Yomi Adegoke on the real-life consequences of social media What is group B strep? Charity says pregnant women ‘in the dark’ Britney Spears: I worked my ass off to get my memoir written
2023-07-12 22:26
What Is Old Bay Seasoning, Anyway?
The original Old Bay seasoning recipe had dozens of ingredients—but McCormick’s current one is shrouded in secrecy.
2023-07-12 21:26
Who is Kristen Kish's partner? 'Top Chef' Season 10 winner to take over as host of Bravo show as Padma Lakshmi bids adieu
Kristen Kish is very well-known in the culinary world and was 'most excited' to take on the new role
2023-07-12 21:26
Domino’s Pizza Shares Jump on a Deal Allowing Orders Through Uber Eats
Domino’s Pizza Inc. shares jumped after the company announced a third-party ordering agreement with Uber Technologies Inc. The
2023-07-12 20:49
An Indian culinary must-have is off the menu as prices jump 400%
From butter chicken to paneer makhani, Indian cuisine is unthinkable without the ubiquitous tomato.
2023-07-12 19:50
The 2024 Mercedes-AMG EQE Brings a Golden Age of Luxury EVs
Mercedes-AMG unveiled its EQS and EQE electric sedans in 2021 and 2022, respectively. Now we have AMG’s first
2023-07-12 17:54
Two HK Mansions Sold at $25 Million Discount, Sing Tao Says
Two Hong Kong mansions located at the Peak have been sold for a combined HK$560 million ($71.5 million),
2023-07-12 14:18
Racism underlies disparities in maternal mortality in Americas -UN report
By Nancy Lapid High rates of pregnancy-related deaths among women of African descent in North and South America
2023-07-12 12:18
China Slams Bulgari For Not Showing Taiwan As Part of Country
Bulgari became the latest foreign brand to face backlash in China, as state and social media alleged that
2023-07-12 11:59
Iowa House passes 6-week abortion ban in special session called by GOP governor
Iowa's state House passed a bill Tuesday night that would ban most abortions in the state as early as six weeks into pregnancy, acting quickly in the special session ordered by GOP Gov. Kim Reynolds with the sole purpose of restricting the procedure in the state.
2023-07-12 11:57
Australia Gives China Extra Month to Decide on Barley Tariffs
Australia has agreed to China’s request for an extra month to decide whether to lift duties on Australian
2023-07-12 11:24
Padma Lakshmi passes torch to 'Top Chef' champ Kristen Kish as new host of the cooking competition
Padma Lakshmi is expressing pride for her successor as host of Bravo's longstanding hit cooking competition show "Top Chef."
2023-07-12 09:54